Vitamin D can reduce the risk for non-Hodgkin lymphoma

A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers.

A scientific study, carried out between 1985 and 2002 with 29,133 male smokers in Finland, examined the relationship between serum 25-hydroxyvitamin D (25(OH)D) and the incidence of non-Hodgkin's lymphoma. It concluded that circulating 25(OH)D may provide a protective effect in the development of non-Hodgkin's lymphomas. Further details can be found in the study.
Lim U, Freedman DM, Hollis BW, Horst RL, Purdue MP, Chatterjee N, Weinstein SJ, Morton LM, Schatzkin A, Virtamo J, Linet MS, Hartge P, Albanes D. A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers. Int J Cancer. 2009 Feb 15;124(4):979-86.



Leave a Reply